Pharmaceutical Manufacturing Landscape Reshaping

Sudhakar Singh, Managing Editor

With the rising demand for generics and increasing investments in pharmaceutical R&D, the role of pharmaceutical contract manufacturers is becoming more and more prominent. As the trends reshape the pharmaceutical manufacturing landscape, we have come up with this special issue focusing exclusively on this niche segment. The cover story of this issue features Nitin Lifesciences/Nichepharm which is a rapidly growing Indian pharmaceutical company with a strong presence in injectable manufacturing. Nitin Lifesciences/Nichepharm has been a quality conscious manufacturers and its focus has been on producing zero defect products.

With the company’s largest capacities in injectable space and economies of scale, it is able to pass on the competitive pricing advantage to its customers. With a combined capacity of over 1.5 billion units per annum, Nitin and Nichepharm combined are catering to around 10 percent of total injectable production in India. Also featuring in this issue is Akums which is a technology driven pharmaceutical company specializing in R&D, manufacturing, and marketing of generic and branded formulations. It has been consistently responding to the ever changing Pharma needs, manufacturing TOP ORG brands for renowned Pharma houses and multi-national companies. It has more than 4000 formulations spread across 13000 brands in the therapeutic segment with wide range in Allopathic, Ayurvedic/Herbal, Nutraceuticals & Veterinary formulations to both the domestic and international markets.

Reading on, you will find more stories on the other top players in this field. Keeping tabs on this market, we have shortlisted the top 10 companies that have exhibited an unrelenting pursuit for excellence. By proving their dedication to fulfilling customer expectations and contributing to the market’s evolution through their innovative disposition, these companies are blazing a trail for others to follow and setting an example for them.

We look forward to receiving your feedback and suggestions.

© 2024 India Pharma Outlook. All Rights Reserved.